Idarubicin-impurities | Pharmaffiliates

idarubicin

The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. An orally administered anthracycline antineoplastic.Reference standards of Idarubicin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Idarubicin-d3
    [catalogue_number] => PA STI 052510
    [category_ids] => ,74,98,78,70,82,
    [chemical_name] => 
    [weight] => 500.51
    [form] => C26H24D3NO9
    [cas] => NA
    [pslug] => idarubicin-d3-pasti052510
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 052510

Idarubicin-d3


  • Catalogue No.:PA STI 052510

  • CAS :

    NA

  • Molecular Formula : C26H24D3NO9

  • Molecular Weight : 500.51

stdClass Object
(
    [pname] => Idarubicinol-d4 (Mixture of Diastereomers)
    [catalogue_number] => PA STI 052520
    [category_ids] => ,74,98,78,70,82,
    [chemical_name] => 
    [weight] => 503.53
    [form] => C26H25D4NO9
    [cas] => NA
    [pslug] => idarubicinol-d4-mixture-of-diastereomers-pasti052520
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 052520

Idarubicinol-d4 (Mixture of Diastereomers)


  • Catalogue No.:PA STI 052520

  • CAS :

    NA

  • Molecular Formula : C26H25D4NO9

  • Molecular Weight : 503.53